Tato provides an intelligent digital physiotherapy platform offering personalized treatment plans and tele-physiotherapy services for musculoskeletal pain. The platform leverages data-driven assessments and remote interventions to improve patient recovery and manage chronic pain.
Funding
Funding not disclosed
Founders
Product
Problem
Musculoskeletal pain is a significant global health issue, leading to substantial economic costs through lost productivity and increased healthcare expenditures. Traditional treatment approaches often lack personalization and accessibility, contributing to suboptimal patient outcomes and prolonged recovery periods.
Solution
Tato offers an intelligent digital physiotherapy platform designed to address musculoskeletal pain. The platform provides personalized treatment plans and tele-physiotherapy services, leveraging a data-driven approach to patient care. By integrating advanced assessment tools with remote therapeutic interventions, Tato aims to enhance patient recovery and reduce the overall economic burden associated with chronic pain management. The service facilitates a structured care pathway, from initial risk stratification to ongoing telemonitoring, ensuring continuous support and adherence to treatment protocols.
Target Audience
Tato targets healthcare payers, including health insurance providers and self-insured companies, as well as employers seeking to improve employee well-being and reduce absenteeism related to musculoskeletal conditions.
Features
- Personalized digital physiotherapy treatment plans tailored to individual patient needs.
- Tele-physiotherapy sessions conducted by specialized pain physiotherapists.
- Initial patient assessment for risk stratification and identification of potential structural injuries or serious conditions.
- Customized care pathways for acute pain, chronic pain, and post-surgical rehabilitation.
- Telemonitoring services to ensure patient adherence, engagement, and ongoing support post-treatment.
- Data-driven insights to track patient progress and inform treatment adjustments.